Gel Mark Ultra Biopsy Site Marker - Marker, lesion localization, implantable

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

から入手可能:

Bard Australia Pty Ltd

クラス:

Class III

製:

SenoRx Inc 1625 W 3rd Street, Tempe, AZ, 82581 United States Of America

治療領域:

40808 - Marker, lesion localization, implantable

適応症:

A disposable applicator containing resorbable polylactic acid/polyglycolic acid (PLA/PGA) pellets with an embedded stainless steel radiopaque wireform, intended for long term radiographic marking of the biospy site. Pellets are visible via ultrasound for approx. 6 weeks and resorbed in approx. 12 weeks. The pellets are deployed from the applicator through the biopsy device into the biopsy cavity. An implant used to radiographically mark breast tissue during a percutaneous breast biopsy procedure.

認証ステータス:

A

承認日:

2009-03-11